Medtronic Seeks Rehearing In Stent Patent Appeal

Law360 (February 11, 2008, 12:00 AM EST) -- Medtronic Inc. and Boston Scientific Corp. have asked a court to rehear their appeal of a jury verdict that found they infringed Cordis Corp.'s coronary stent patents, saying the court's decision failed to take into account recent case law on jury instructions.

The Federal Circuit erred in its January decision affirming the verdict against Medtronic and Boston Scientific, said William Atkins, an attorney for the defendants, in a Feb. 4 petition.

The jury was instructed that it could not combine different past prior art references in...
To view the full article, register now.